Rapid Acceleration of Diagnostics (RADx) Initiative

Linked circles showing laboratory testing, medical examination, and a depiction of a virus

Overview

Overview

Need To Add Description Here (This image might not work for us...)

 

 

The Rapid Acceleration of Diagnostics (RADx) initiative invests in innovative technologies as a way to speed development of rapid and widely accessible COVID-19 testing. Finalist technologies will be matched with technical, business, and manufacturing experts to increase odds of success.

Usability evaluations of the novel technologies will be conducted by CACP’s HomeLab, in partnership with The Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME-POCT). These evaluations can begin at the design phase of the process and will conclude with user testing for the final product.  User testing will occur wherever the novel test is intended to be used: in the home, in a clinic, in a pharmacy, or in any appropriate community setting. Evaluations will focus on the individual who administers a COVID-19 test.

 

For more information contact Sarah Farmer

Participant FAQ

Participant FAQ

What is the project about?

The Rapid Acceleration of Diagnostics (RADx) initiative invests in innovative technologies as a way to speed development of rapid and widely accessible COVID-19 testing. RADx Tech initiative https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-tech “aims to speed the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improve clinical laboratory tests, that can directly detect the virus. RADx Tech will expand the Point-of-Care Technologies Research Network (POCTRN) established several years ago by NIH’s National Institute of Biomedical Imaging and Bioengineering (NIBIB). The network will use a flexible, rapid process to infuse funding and enhance technology designs at key stages of development, with expertise from technology innovators, clinical testing, regulatory affairs, entrepreneurs, and business leaders.”

  

Who is conducting the work?

Homelab https://cacp.gatech.edu/research/accessibility/HomeLab a unit of the Center for Advanced Communications Policy (CACP), at Georgia Tech, is a residence-based network of older adults who have agreed to participate in research studies in their home. Generally, participants are age 55-99; with a variety of medical conditions are represented, from health to those who have conditions such as COPD, diabetes, congestive heart failure, arthritis, and other normative age-related declines. In addition, HomeLab Kids is made up of child participants, with a focus on childhood medical conditions (asthma, juvenile diabetes, special dietary needs, ADHD, Autism spectrum disorder, and chronic diseases). 

 

What is HomeLab’s approach?

Usability evaluations of the novel technologies are conducted by CACP’s HomeLab,https://cacp.gatech.edu/research/accessibility/HomeLab in partnership with The Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME-POCT). These evaluations can begin at the design phase of the process and will conclude with user testing for the final product.  User testing will occur wherever the novel test is intended to be used: in the home, in a clinic, in a pharmacy, or in any appropriate community setting. Evaluations will focus on the individual who administers a COVID-19 test.

 

How does HomeLab conduct Usability Evaluations?

As is the standard procedure, HomeLab obtain Georgia Tech Institutional Review Board (IRB) approval for the conduct of all research involving human subjects. RADx usability research protocols and recruitment processes are tailored based on the specifics of each novel test and the tasks involved for each test. This ensures that all participants are protected and can be confident that the protocols follow best practice safety and ethical guidelines.

 

For each test, 15-20 participants will be recruited, and a projected 10-20 tests will pass through the program. Overall, between 150 and 400 participants will participate in the program. Participants will be recruited to be representative of the intended user population for each test. 

 

Usability evaluations will be conducted for all of the pertinent contexts: in a home setting; primary care clinics, hospital emergency rooms, and pharmacies, in a clinical lab, or in the community, depending on the intended use location of the tests. 

 

I’m interested in knowing more – who do I contact?

https://cacp.gatech.edu/research/accessibility/HomeLab

https://cacp.gatech.edu/research/accessibility/HomeLab 

For more information on participation: 

Georgia Tech HomeLab

500 10th Street NW

Atlanta, GA 30332 - 0620

Phone: 404-385-4614

 

Industry FAQ

Industry FAQ

What is the project about?

The Rapid Acceleration of Diagnostics (RADx) initiative invests in innovative technologies as a way to speed development of rapid and widely accessible COVID-19 testing. RADx Tech initiativehttps://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-tech   “aims to speed the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improve clinical laboratory tests, that can directly detect the virus. RADx Tech will expand the Point-of-Care Technologies Research Network(POCTRN) established several years ago by NIH’s National Institute of Biomedical Imaging and Bioengineering (NIBIB). The network will use a flexible, rapid process to infuse funding and enhance technology designs at key stages of development, with expertise from technology innovators, clinical testing, regulatory affairs, entrepreneurs, and business leaders.”

 

How does RADx work?

The NIH invites scientists and inventors with a candidate rapid testing technology to compete in a national “shark tank”-type COVID-19 testing challenge. The program has up to $500 million allocated to fund the various phases of development. The technologies will undergo a highly competitive, rapid three-phase selection process to identify the best candidates for at-home or point-of-care tests for COVID-19. Finalists will be matched with technical, business, and manufacturing experts to increase the odds of success. If certain selected technologies are already relatively far along in development, they can be advanced immediately to the appropriate step in the commercialization process. Details and application information are available on the POCTRN site: https://www.poctrn.org/radx 

 

Who is conducting the work?

HomeLab https://cacp.gatech.edu/research/accessibility/HomeLab a unit of the Center for Advanced Communications Policy (CACP), at Georgia Tech, is a residence-based network of older adults who have agreed to participate in research studies in their home. Generally, participants are age 55-99; with a variety of medical conditions are represented, from health to those who have conditions such as COPD, diabetes, congestive heart failure, arthritis, and other normative age-related declines. In addition, HomeLab Kids is made up of child participants, with a focus on childhood medical conditions (asthma, juvenile diabetes, special dietary needs, ADHD, Autism spectrum disorder, and chronic diseases). 

 

What is HomeLab’s approach?

Usability evaluations of the novel technologies are conducted by CACP’s HomeLab, https://cacp.gatech.edu/research/accessibility/HomeLab in partnership with The Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME-POCT). These evaluations can begin at the design phase of the process and will conclude with user testing for the final product.  User testing will occur wherever the novel test is intended to be used: in the home, in a clinic, in a pharmacy, or in any appropriate community setting. Evaluations will focus on the individual who administers a COVID-19 test.

 

What is HomeLab’s overall evaluation process?

HomeLab will conduct a three-pronged evaluation:

  • Human Factors Analysis
  • Expert Heuristic Evaluation
  • Usability Evaluation 

 

If the test under evaluation is deemed to have significant usability flaws at the end of the Human Factors Analysis, project directors will be briefed and given the opportunity to terminate the evaluation for that test


 

What is HomeLab’s Human Factors Evaluation process?

HomeLab conducts a Design Failure Modes and Effects Analysis (DFMEA) in which the tasks required to complete the testing process will be identified, as well as potential errors for each task. Following this, the frequency of potential errors will be estimated as well as the associated impact of each potential error. During usability testing, the frequency of each error will be validated and the DFMEA will be updated. HomeLab will also estimate cognitive, sensory, and physical workloads associated with the use of each kit. 

 

What is HomeLab’s Expert Heuristic Evaluation?

Two or more HomeLab researchers independently review each test kit in a lab setting to identify features of the test likely to cause errors, as well as features of the test that may cause other usability issues.  

HomeLab researchers utilize a heuristic evaluation tailored to each test based on FDA usability guidance, sound human factors design principles, and lab experience in the design and evaluation of medical devices. 

 

How does HomeLab conduct Usability Evaluations?

As is the standard procedure, HomeLab obtain Georgia Tech Institutional Review Board (IRB) approval for the conduct of all research involving human subjects. RADx usability research protocols and recruitment processes are tailored based on the specifics of each novel test and the tasks involved for each test. 

 

For each test, 15-20 participants will be recruited, and a projected 10-20 tests will pass through the program. Overall, between 150 and 400 participants will participate in the program. Participants will be recruited to be representative of the intended user population for each test. 

 

Usability evaluations will be conducted for all of the pertinent contexts: in a home setting; primary care clinics, hospital emergency rooms, and pharmacies, in a clinical lab, or ; in the community, depending on the intended use location of the tests. 

 

What are the Metrics used in the Usability Evaluations?

HomeLab will report, at a minimum, on the following metrics: 

  • Usability: The extent to which a test can be used by specified users to achieve specified goals with effectiveness, efficiency, and satisfaction in a specified context of use.
  • Effectiveness: Is the accuracy and completeness with which users achieve specified goals. This includes: percent task completion, frequency and type of errors, frequency of required assistance from evaluator to complete task or test, frequency of user access to documentation or guidance.
  • Efficiency: The resources expended in relation to the accuracy and completeness with which users achieve goals; the time it takes to complete a task, and the mean time taken to complete a test
  • Satisfaction: Elements of satisfaction include: lack of discomfort, and positive attitudes toward the use of a test 
  • Context of use: This includes an assessment of the users, tasks, equipment, and physical environment in which evaluation takes place; the setting and type of space used for usability evaluation, and, relevant circumstances that could affect results.

 

I’m interested in knowing more – who do I contact?

For information on HomeLab, see https://cacp.gatech.edu/research/accessibility/HomeLab

For a description of capabilities see https://cacp.gatech.edu/research/accessibility/HomeLab 

For more information: 

Georgia Tech HomeLab

500 10th Street NW

Atlanta, GA 30332 - 0620

Phone: 404-385-4614

homelab@cacp.gatech.edu 

Technology and Disability Policy Highlights - January 2020

Date
February 7, 2020

In January, The Wireless E911 Location Accuracy Requirements [PS Docket No. 07-114] final ruling was published in the Federal Register, which focused on the adoption of a z-axis location accuracy metric. The Federal Communications Commission (FCC) also noted that it now requires nationwide commercial mobile radio service (CMRS) providers to deploy dispatchable location technology to meet the latest rulemaking. This final ruling is effective on March 16, 2020.

Technology and Disability Policy Highlights - December 2019

Date
January 14, 2020

In December, the Telephone Robocall Abuse Criminal Enforcement and Deterrence (TRACED) Act was signed into law [Public Law No: 116-105], a bipartisan legislative effort to reduce the excessive number of robocalls that Americans receive daily. The Federal Communications Commission (FCC or Commission) now has additional tools and flexibilities to combat malicious caller ID spoofing, which will allow the FCC to pursue scammers. The law also extends the statute of limitations for the FCC to criminally pursue violators.

CACP Researchers Attend CES 2020

Date
January 14, 2020

CACP Executive Director Brad Fain and Research Scientist Sarah Farmer attended the 2020 Consumer Electronics Show (CES) January 6-11, in Las Vegas, Nevada. The key objective was obtaining a sense of upcoming technologies that were focused on or had components of accessibility and usability, or could enhance the quality of life for people with disabilities, the aging, and other vulnerable populations. Specific areas included meeting with NIST's Public Safety Communication Research Division and other first responder related communication technology companies.

Technology and Disability Policy Highlights - Winter Issue - December 2018-January 2019

Date
February 8, 2019

In the regulatory space, the Federal Communications Commission (FCC) is seeking input from people with disabilities and other stakeholders about how best to facilitate the coordination of communications providers, power companies, and the Public Safety and Homeland Security Bureau to enable a robust and rapid response to emergencies. Specifically, the concern is keeping people connected to communications in the event of power outages or service interruptions.

Brad Fain Named Executive Director of Center of Advanced Communications Policy

Date
February 8, 2019

Brad Fain, principal research scientist at the Georgia Tech Research Institute (GTRI) and at the Center for Advanced Communications Policy (CACP), has been appointed as executive director of CACP. The appointment was announced on January 2, 2019 by Ivan Allen College of Liberal Arts Dean Jacqueline Royster.

Mobile Phone Accessibility Review

Date
February 13, 2019

The Federal Communications Commission (FCC) has a statutory obligation to evaluate the impact of their regulations that implement the Twenty-First Century Communications and Video Accessibility Act (CVAA). Every two-years the FCC submits a report to Congress on the state of industry compliance with the CVAA. In anticipation of the FCC’s call for stakeholder input to inform their 2018 CVAA Biennial Report, the Wireless RERC conducted a 2017 Mobile Phone Accessibility Review (Accessibility Review/Review).

Nathan Moon gives presentation at State of the Science conference

Date
February 15, 2019

Nathan Moon and Fran Harris (CATEA, Georgia Tech) recently gave an invited presentation at State of the Science Conference for the University of New Hampshire's Rehabilitation Research and Training Center on Employment Policy and Measurement (EPM-RRTC). The conference was held at the National Academy of Sciences Building in Washington, DC, on February 12, 2019.